D. Knowles

Antitumor efficacy of a novel class of non-thiol-containing peptidomimetic inhibitors of farnesyltransferase and geranylgeranyltransferase I: combination therapy with the cytotoxic agents cisplatin, Taxol, and gemcitabine.

S. Sebti, A. Hamilton, Jiazhi Sun, 1999, Cancer research.

Cytotoxic Agents Cisplatin , Taxol , and Gemcitabine Geranylgeranyltransferase I : Combination Therapy with the Peptidomimetic Inhibitors of Farnesyltransferase and Antitumor Efficacy of a Novel Class of Non-thiol-containing Updated Version

S. Sebti, A. Hamilton, Jiazhi Sun, 1999 .

Potent and selective inhibitors of PI3Kδ: obtaining isoform selectivity from the affinity pocket and tryptophan shelf.

Steve Price, A. Nadin, BinQing Wei, 2013, Bioorganic & medicinal chemistry letters.

Structure-based design of imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase.

S. Sebti, A. Hamilton, Jiazhi Sun, 2006, Organic & biomolecular chemistry.

Inhibitors of protein farnesyltransferase as novel anticancer agents.

S. Sebti, A. Hamilton, M. Blaskovich, 2002, Current topics in medicinal chemistry.

Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines

S. Sebti, A. Hamilton, Y. Qian, 1997, Oncogene.

Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype

J. Bennink, P. Doherty, B. Knowles, 1978, The Journal of experimental medicine.